Argenx
Manufacturing · Netherlands · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
Laarderhoogtweg 25, Amsterdam, North Hol...Phone Number
+31 107038441Website
www.argenx.comRevenue
$2.6 BillionStock Symbol
ARGXIndustry
About Argenx
Argenx Org Chart
Is Argenx your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Argenx launches new products
Argenx, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Argenx has new funding data
Click to see if Argenx had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Argenx
Check out if Argenx is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Argenx recently announced quarterly report
Check if Argenx has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Argenx is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Argenx is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Argenx.
Argenx financials insights
Gather financial insights about Argenx, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Stock Offering
$54.4M
Stock Offering
$100M
Stock Offering
$750M
Argenx Tech Stack
A closer look at the technologies used by Argenx
Most Recent Scoops
Argenx News & Media
argenx to Present at BofA Securities 2026 Health Care Conference
May 6, 2026 Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that Karen Massey, Chief Executive Officer, will present at the BofA Securities 2026 Health Care Conference on Tuesday, May 12, 2026 at 10:40 a.m. PT.Here’s Why Argenx SE (ARGX) Slipped in Q1
Baron Capital, an investment management company, released its Q1 2026 investor letter for the “Baron Health Care Fund”. A copy of the letter is available to download here. Baron Health Care Fund (the Fund) declined 6.97% (Institutional Shares) in the quarter, compared to the 4.88% decline for the Russell 3000 Health Care Index (the Benchmark) and […]Analysts Highlight Vyvgart Expansion as Major Growth Driver for Argenx (ARGX)
Argenx SE (NASDAQ:ARGX) ranks among the best growth stocks to buy and hold for the long term. Following the company’s Q4 results, Oppenheimer increased its price target for Argenx SE (NASDAQ:ARGX) to $1,060 from $1,040 on February 26 while keeping an Outperform rating. The company reported earnings per share of $8.02, exceeding the projected $5.95. […]Argenx (ARGX) 2025 Net Product Sales Rise 90% to $4.2B as First Annual Profit Reached
Argenx SE (NASDAQ:ARGX) is one of the best NASDAQ stocks to buy according to hedge funds. On February 26, Argenx reported earnings for 2025, achieving its first year of annual operating profitability with $4.2 billion in net product sales, a 90% increase over 2024. This growth was fueled by the global adoption of VYVGART, which […]
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Argenx
At argenx, we build our culture from the collective power of the team and the knowledge that together, we are better. We are all co-owners of this company; we recognize that each individual performance contributes to the broader purpose. We align the personal growth of our employees with the shared goals of the organization.... Read More